Riskpilot← Back to searchSign inGet full accessKIMOVI ApS
APSDissolvedCVR 34598762Smedevej 38CManufacture of medical and dental instruments and supplies · NACE 3250Est. 20121 employees
Revenue 2024
DKK 32K
-502% vs 2023
EBITDA margin
100.0%
+502% vs 2023
Equity ratio
-619.7%
Financial strength
Net profit 2024
DKK -14K
+73% vs 2023
| Revenue | DKK 32K | -502% |
| EBITDA | DKK 32K | +502% |
| Net profit | DKK -14K | +73% |
| Total assets | DKK 117K | -40% |
| Equity | DKK -723K | -2% |
| Employees | 1 | — |
Legal name
KIMOVI ApS
CVR number
34598762
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
21. juni 2012
Share capital
DKK 3.698.666
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af den administrerende direktør eller af bestyrelsesformanden i forening med 2 bestyrelsesmedlemmer eller af den samlede bestyrelse
Address
Smedevej 38C
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -2.574 | -1.596 | -2.414 | -1.019 | 115 | -352 | 19 | 43 | -27 | -20 | -8 | 32 |
| Staff expenses | -632 | -1.327 | -972 | -657 | -441 | -210 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -3.206 | -2.923 | -3.386 | -1.677 | -326 | -562 | 19 | 43 | -27 | -20 | -8 | 32 |
| Depreciation & amort. | -27 | -25 | -25 | -25 | -23 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3.233 | -2.948 | -3.411 | -1.702 | -349 | -562 | 19 | 43 | -27 | -20 | -8 | 32 |
| Net financials | -177 | -191 | -252 | -24 | -96 | -25 | -30 | -36 | -39 | -40 | -43 | -46 |
| Profit before tax | -3.410 | -3.140 | -3.663 | -1.726 | -445 | -586 | -11 | 7 | -66 | -60 | -51 | -14 |
| Tax | -0 | -0 | -627 | -32 | -32 | 32 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -3.410 | -3.140 | -3.036 | -1.694 | -414 | -618 | -11 | 7 | -66 | -60 | -51 | -14 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 850 | 3.235 | 1.620 | 1.765 | 716 | 194 | 181 | 203 | 205 | 195 | 195 | 117 |
| Equity | -2.485 | -625 | 1.030 | -664 | 238 | -530 | -541 | -534 | -599 | -659 | -710 | -723 |
| Long-term debt | 3.227 | 3.410 | 212 | 1.481 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 108 | 450 | 378 | 948 | 479 | 724 | 721 | 736 | 804 | 854 | 905 | 840 |
| Total debt | 3.335 | 3.860 | 590 | 2.429 | 479 | 724 | 721 | 736 | 804 | 854 | 905 | 840 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20132024
Equity ratio
-619.7%
This company
38.2%
Market median
-1722% vs market
20132024
Return on equity
-1369500.0%
This company
18.4%
Market median
-7443035% vs market
20132024
Net profit margin
-43.0%
This company
8.1%
Market median
-631% vs market
20132024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20132024
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-06-21 – 2013-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AK Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
JW Management | Management | 2012 | — | — |
LM Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
TSM-KONSULENTEN ApS | Company | 15.0% | 15.0% | 2018 |
Styrelsen for Forskning og Uddannelse | Company | 33.3% | 33.3% | 2017 |
LIMOVI ApS | Company | 15.0% | 15.0% | 2017 |
MR INV 3 ApS | Company | 5.0% | 5.0% | 2015 |
Uddannelses- og Forskningsstyrelsen | Company | 20.0% | 20.0% | 2017 |
2bak ApS | Company | 5.0% | 5.0% | 2021 |
HEART2START ApS | Company | 50.0% | 50.0% | 2018 |
| Individual | 20.0% | 20.0% | 2015 | |
SYDDANSK INNOVATION ApS | Company | 10.0% | 10.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KIMOVI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Allan Kim Gercke Malmdorf | Chief Executive Officer | 0 companies |
| Jan Waage | Management | 0 companies |
| Lennart Michael Funch | Chief Executive Officer | 0 companies |
| Catharina Ratzer | Board of Directors | 0 companies |
| Søren Georg Jensen | Chairman | 0 companies |
| Charlotte Kjærgaard | Board of Directors | 0 companies |